CCL2 and atherosclerosis: The results suggested that STS could significantly reduce the concentration levels of pro-inflammatory cytokines IL-6, TNF-α, and IL-1β, adhesion molecules ICAM-1 and p-selectin, and chemokines fractalkine and MCP-1 in AS and ASCVD patients.